Atypical hemolytic–uremic syndrome
The hemolytic–uremic syndrome, which is characterized by nonimmune hemolytic anemia,
thrombocytopenia, and renal impairment, occurs most frequently in young children. Most …
thrombocytopenia, and renal impairment, occurs most frequently in young children. Most …
Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome
The aim of this review is to examine recent advances in experimental and clinical research
relevant to the pathogenesis of diarrhea-associated hemolytic uremic syndrome with special …
relevant to the pathogenesis of diarrhea-associated hemolytic uremic syndrome with special …
aHUS caused by complement dysregulation: new therapies on the horizon
AM Waters, C Licht - Pediatric Nephrology, 2011 - Springer
Atypical hemolytic uremic syndrome (aHUS) is a heterogeneous disease that is caused by
defective complement regulation in over 50% of cases. Mutations have been identified in …
defective complement regulation in over 50% of cases. Mutations have been identified in …
HUS and TTP: variable expression of a single entity
G Remuzzi, S Garella - Kidney international, 1987 - Elsevier
Case presentation A 41-year-old man was admitted to the Division of Nephrology, Ospedali
Riuniti di Bergamo, Bergamo, Italy. He reported vomiting, watery diarrhea, abdominal pain …
Riuniti di Bergamo, Bergamo, Italy. He reported vomiting, watery diarrhea, abdominal pain …
Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.
S Moncada - British journal of pharmacology, 1982 - ncbi.nlm.nih.gov
Throughout Sir John Henry Gaddum's highly productive scientific life, two main interests are
clearly discernible. One is the study of pharmacologically active substances obtained from …
clearly discernible. One is the study of pharmacologically active substances obtained from …
The hemolytic uremic syndrome
G Remuzzi, P Ruggenenti - Kidney international, 1995 - Elsevier
Hemolytic uremic syndrome (HUS) is a disease of non-immune hemolytic anemia,
thrombocytopenia and renal failure due to platelet thrombi in the microcirculation of the …
thrombocytopenia and renal failure due to platelet thrombi in the microcirculation of the …
Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome
PE Ray, XH Liu - Pediatric Nephrology, 2001 - Springer
The term hemolytic uremic syndrome (HUS) was first introduced to describe a
heterogeneous group of diseases characterized by microangiopathic hemolytic anemia …
heterogeneous group of diseases characterized by microangiopathic hemolytic anemia …
Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy
AM JACKSON, BD ROSE, LG GRAFF… - Annals of internal …, 1984 - acpjournals.org
Five patients with carcinoma developed thrombotic microangiopathy (characterized by renal
insufficiency, microangiopathic hemolytic anemia, and usually thrombocytopenia) after …
insufficiency, microangiopathic hemolytic anemia, and usually thrombocytopenia) after …
Prostacyclin and arterial wall biology.
S Moncada - Arteriosclerosis: An Official Journal of the American …, 1982 - Am Heart Assoc
Arachidonic acid, the precursor of all bisenoic prostaglandins, is the most common fatty acid
present in cellular phospholipids and can be obtained directly from the diet or by …
present in cellular phospholipids and can be obtained directly from the diet or by …
Management of thrombotic thrombocytopenic purpura.
GA Rock - British journal of haematology, 2000 - search.ebscohost.com
Review Page 1 496 q 2000 Blackwell Science Ltd Review MANAGEMENT OF
THROMBOTIC THROMBOCYTOPENIC PURPURA The syndrome Thrombotic …
THROMBOTIC THROMBOCYTOPENIC PURPURA The syndrome Thrombotic …